{"transactions":[{"id":1818917,"issuer":{"id":8048,"kind":"organization","name":"CNS Pharmaceuticals, Inc."},"owners":[{"id":110982,"kind":"person","name":"Priebe Waldemar","position":1,"cik":"0001678516","reported_name":"Priebe Waldemar","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-08-01T17:10:16.000Z","date":"2023-03-28","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":1.04,"value":10400.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Consists of: (i) shares of common stock held by a limited liability company; and (ii) shares held by Houston Pharmaceuticals, Inc."}],"balance_after":156807,"source":{"system":"sec-edgar","filing":"0000897069-23-001044","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1678516/000089706923001044/form4.xml","form_type":"4"}},{"id":1818916,"issuer":{"id":8048,"kind":"organization","name":"CNS Pharmaceuticals, Inc."},"owners":[{"id":110982,"kind":"person","name":"Priebe Waldemar","position":1,"cik":"0001678516","reported_name":"Priebe Waldemar","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-08-01T17:10:16.000Z","date":"2023-03-27","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":1.09,"value":5450.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Consists of: (i) shares of common stock held by a limited liability company; and (ii) shares held by Houston Pharmaceuticals, Inc."}],"balance_after":166807,"source":{"system":"sec-edgar","filing":"0000897069-23-001044","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1678516/000089706923001044/form4.xml","form_type":"4"}},{"id":1818915,"issuer":{"id":8048,"kind":"organization","name":"CNS Pharmaceuticals, Inc."},"owners":[{"id":110982,"kind":"person","name":"Priebe Waldemar","position":1,"cik":"0001678516","reported_name":"Priebe Waldemar","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-08-01T17:10:16.000Z","date":"2023-03-24","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":1.08,"value":5400.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Consists of: (i) shares of common stock held by a limited liability company; and (ii) shares held by Houston Pharmaceuticals, Inc."}],"balance_after":171807,"source":{"system":"sec-edgar","filing":"0000897069-23-001044","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1678516/000089706923001044/form4.xml","form_type":"4"}},{"id":1818914,"issuer":{"id":8048,"kind":"organization","name":"CNS Pharmaceuticals, Inc."},"owners":[{"id":110982,"kind":"person","name":"Priebe Waldemar","position":1,"cik":"0001678516","reported_name":"Priebe Waldemar","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-08-01T17:10:16.000Z","date":"2023-03-23","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":1.08,"value":10800.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Consists of: (i) shares of common stock held by a limited liability company; and (ii) shares held by Houston Pharmaceuticals, Inc."}],"balance_after":176807,"source":{"system":"sec-edgar","filing":"0000897069-23-001044","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1678516/000089706923001044/form4.xml","form_type":"4"}},{"id":1818913,"issuer":{"id":8048,"kind":"organization","name":"CNS Pharmaceuticals, Inc."},"owners":[{"id":110982,"kind":"person","name":"Priebe Waldemar","position":1,"cik":"0001678516","reported_name":"Priebe Waldemar","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-08-01T17:10:16.000Z","date":"2023-03-22","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":1.08,"value":5400.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Consists of: (i) shares of common stock held by a limited liability company; and (ii) shares held by Houston Pharmaceuticals, Inc."}],"balance_after":186807,"source":{"system":"sec-edgar","filing":"0000897069-23-001044","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1678516/000089706923001044/form4.xml","form_type":"4"}},{"id":1818912,"issuer":{"id":8048,"kind":"organization","name":"CNS Pharmaceuticals, Inc."},"owners":[{"id":110982,"kind":"person","name":"Priebe Waldemar","position":1,"cik":"0001678516","reported_name":"Priebe Waldemar","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-08-01T17:10:16.000Z","date":"2023-03-21","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":1.1,"value":5500.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Consists of: (i) shares of common stock held by a limited liability company; and (ii) shares held by Houston Pharmaceuticals, Inc."}],"balance_after":191807,"source":{"system":"sec-edgar","filing":"0000897069-23-001044","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1678516/000089706923001044/form4.xml","form_type":"4"}},{"id":1818911,"issuer":{"id":8048,"kind":"organization","name":"CNS Pharmaceuticals, Inc."},"owners":[{"id":110982,"kind":"person","name":"Priebe Waldemar","position":1,"cik":"0001678516","reported_name":"Priebe Waldemar","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-08-01T17:10:16.000Z","date":"2023-03-20","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":1.08,"value":5400.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Consists of: (i) shares of common stock held by a limited liability company; and (ii) shares held by Houston Pharmaceuticals, Inc."}],"balance_after":196807,"source":{"system":"sec-edgar","filing":"0000897069-23-001044","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1678516/000089706923001044/form4.xml","form_type":"4"}},{"id":1818910,"issuer":{"id":8048,"kind":"organization","name":"CNS Pharmaceuticals, Inc."},"owners":[{"id":110982,"kind":"person","name":"Priebe Waldemar","position":1,"cik":"0001678516","reported_name":"Priebe Waldemar","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-08-01T17:10:16.000Z","date":"2023-03-17","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":1.13,"value":5650.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Consists of: (i) shares of common stock held by a limited liability company; and (ii) shares held by Houston Pharmaceuticals, Inc."}],"balance_after":201807,"source":{"system":"sec-edgar","filing":"0000897069-23-001044","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1678516/000089706923001044/form4.xml","form_type":"4"}},{"id":1818909,"issuer":{"id":8048,"kind":"organization","name":"CNS Pharmaceuticals, Inc."},"owners":[{"id":110982,"kind":"person","name":"Priebe Waldemar","position":1,"cik":"0001678516","reported_name":"Priebe Waldemar","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-08-01T17:10:16.000Z","date":"2023-03-16","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":1.24,"value":6200.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Consists of: (i) shares of common stock held by a limited liability company; and (ii) shares held by Houston Pharmaceuticals, Inc."}],"balance_after":206807,"source":{"system":"sec-edgar","filing":"0000897069-23-001044","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1678516/000089706923001044/form4.xml","form_type":"4"}},{"id":1818908,"issuer":{"id":8048,"kind":"organization","name":"CNS Pharmaceuticals, Inc."},"owners":[{"id":110982,"kind":"person","name":"Priebe Waldemar","position":1,"cik":"0001678516","reported_name":"Priebe Waldemar","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-08-01T17:10:16.000Z","date":"2023-03-15","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":1.22,"value":6100.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Consists of: (i) shares of common stock held by a limited liability company; and (ii) shares held by Houston Pharmaceuticals, Inc."}],"balance_after":211807,"source":{"system":"sec-edgar","filing":"0000897069-23-001044","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1678516/000089706923001044/form4.xml","form_type":"4"}},{"id":1818907,"issuer":{"id":8048,"kind":"organization","name":"CNS Pharmaceuticals, Inc."},"owners":[{"id":110982,"kind":"person","name":"Priebe Waldemar","position":1,"cik":"0001678516","reported_name":"Priebe Waldemar","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-08-01T17:10:16.000Z","date":"2023-03-14","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":1.35,"value":6750.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Consists of: (i) shares of common stock held by a limited liability company; and (ii) shares held by Houston Pharmaceuticals, Inc."}],"balance_after":216807,"source":{"system":"sec-edgar","filing":"0000897069-23-001044","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1678516/000089706923001044/form4.xml","form_type":"4"}},{"id":1818906,"issuer":{"id":8048,"kind":"organization","name":"CNS Pharmaceuticals, Inc."},"owners":[{"id":110982,"kind":"person","name":"Priebe Waldemar","position":1,"cik":"0001678516","reported_name":"Priebe Waldemar","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-08-01T17:10:16.000Z","date":"2023-03-13","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":1.3,"value":6500.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Consists of: (i) shares of common stock held by a limited liability company; and (ii) shares held by Houston Pharmaceuticals, Inc."}],"balance_after":221807,"source":{"system":"sec-edgar","filing":"0000897069-23-001044","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1678516/000089706923001044/form4.xml","form_type":"4"}},{"id":1818905,"issuer":{"id":8048,"kind":"organization","name":"CNS Pharmaceuticals, Inc."},"owners":[{"id":110982,"kind":"person","name":"Priebe Waldemar","position":1,"cik":"0001678516","reported_name":"Priebe Waldemar","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-08-01T17:10:16.000Z","date":"2023-03-10","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":1.29,"value":6450.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Consists of: (i) shares of common stock held by a limited liability company; and (ii) shares held by Houston Pharmaceuticals, Inc."}],"balance_after":226807,"source":{"system":"sec-edgar","filing":"0000897069-23-001044","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1678516/000089706923001044/form4.xml","form_type":"4"}},{"id":1818904,"issuer":{"id":8048,"kind":"organization","name":"CNS Pharmaceuticals, Inc."},"owners":[{"id":110982,"kind":"person","name":"Priebe Waldemar","position":1,"cik":"0001678516","reported_name":"Priebe Waldemar","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-08-01T17:10:16.000Z","date":"2022-12-09","kind":"sale","planned":true,"acquired":false,"shares":2798,"price":2.43,"value":6799.14,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Consists of: (i) shares of common stock held by a limited liability company; and (ii) shares held by Houston Pharmaceuticals, Inc."}],"balance_after":231807,"source":{"system":"sec-edgar","filing":"0000897069-23-001044","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1678516/000089706923001044/form4.xml","form_type":"4"}},{"id":1818903,"issuer":{"id":8048,"kind":"organization","name":"CNS Pharmaceuticals, Inc."},"owners":[{"id":110982,"kind":"person","name":"Priebe Waldemar","position":1,"cik":"0001678516","reported_name":"Priebe Waldemar","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-08-01T17:10:16.000Z","date":"2022-12-08","kind":"sale","planned":true,"acquired":false,"shares":5500,"price":2.4,"value":13200.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Consists of: (i) shares of common stock held by a limited liability company; and (ii) shares held by Houston Pharmaceuticals, Inc."}],"balance_after":234605,"source":{"system":"sec-edgar","filing":"0000897069-23-001044","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1678516/000089706923001044/form4.xml","form_type":"4"}},{"id":1818902,"issuer":{"id":8048,"kind":"organization","name":"CNS Pharmaceuticals, Inc."},"owners":[{"id":110982,"kind":"person","name":"Priebe Waldemar","position":1,"cik":"0001678516","reported_name":"Priebe Waldemar","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-08-01T17:10:16.000Z","date":"2022-12-07","kind":"sale","planned":true,"acquired":false,"shares":5500,"price":2.46,"value":13530.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Consists of: (i) shares of common stock held by a limited liability company; and (ii) shares held by Houston Pharmaceuticals, Inc."}],"balance_after":240105,"source":{"system":"sec-edgar","filing":"0000897069-23-001044","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1678516/000089706923001044/form4.xml","form_type":"4"}},{"id":1818901,"issuer":{"id":8048,"kind":"organization","name":"CNS Pharmaceuticals, Inc."},"owners":[{"id":110982,"kind":"person","name":"Priebe Waldemar","position":1,"cik":"0001678516","reported_name":"Priebe Waldemar","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-08-01T17:10:16.000Z","date":"2022-12-06","kind":"sale","planned":true,"acquired":false,"shares":5500,"price":2.47,"value":13585.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Consists of: (i) shares of common stock held by a limited liability company; and (ii) shares held by Houston Pharmaceuticals, Inc."}],"balance_after":245605,"source":{"system":"sec-edgar","filing":"0000897069-23-001044","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1678516/000089706923001044/form4.xml","form_type":"4"}},{"id":2426343,"issuer":{"id":8048,"kind":"organization","name":"CNS Pharmaceuticals, Inc."},"owners":[{"id":110982,"kind":"person","name":"Priebe Waldemar","position":1,"cik":"0001678516","reported_name":"Priebe Waldemar","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-01-25T16:05:13.000Z","date":"2020-05-05","kind":"other","acquired":false,"shares":1495867,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares are held by a limited liability company for which the reporting person's adult child is the sole manager and adult children are sole members. Prior to May 5, 2020, the reporting person was a manager of the limited liability company. The reporting person ceased to be a manager of the limited liability company on May 5, 2020, and since such date has not had any voting or dispositive power over the shares held by the limited liability company. The reporting person has never had a pecuniary interest in the limited liability company."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Consists of: (i) 7,333,133 shares of common stock held by a limited liability company; and (ii) 200,000 shares held by Houston Pharmaceuticals, Inc."}],"balance_after":7533133,"source":{"system":"sec-edgar","filing":"0001683168-22-000460","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1678516/000168316822000460/ownership.xml","form_type":"4"}},{"id":3048762,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":110982,"kind":"person","name":"Priebe Waldemar","position":1,"cik":"0001678516","reported_name":"Priebe Waldemar","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock option (right to buy)","published_at":"2020-08-24T20:04:39.000Z","date":"2020-08-20","kind":"grant","acquired":true,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Issued in connection with the reporting person providing services to the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date."}],"balance_after":100000,"derivative":{"exercise_price":0.96,"expiration_date":"2030-08-20","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001659617-20-000206","document":"wf-form4_159829941790393.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000165961720000206/wf-form4_159829941790393.xml","form_type":"4"}},{"id":4229561,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":110982,"kind":"person","name":"Priebe Waldemar","position":1,"cik":"0001678516","reported_name":"Priebe Waldemar","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-08-18T22:00:28.000Z","date":"2017-08-16","kind":"sale","acquired":false,"shares":100000,"price":1.703,"value":170300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person entered into a private sale agreement for the shares of common stock set forth in the table."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In addition to the shares held directly by the reporting person, The reporting person is a shareholder and control person of IntertechBio Corp. IntertechBio Corp. holds 630,000 shares of Issuer common stock. Pursuant to General Instruction 5(b)(iv) of Form 3, the amount set forth in the table represents the reporting person's proportionate interest in the Issuer common stock beneficially owned by IntertechBio Corp. The reporting person is also a shareholder and control person of Houston Pharmaceuticals, Inc. Houston Pharmaceuticals, Inc. holds 629,000 shares of Issuer common stock. Pursuant to General Instruction 5(b)(iv) of Form 3, the amount set forth in the table represents the reporting person's proportionate interest in the Issuer common stock beneficially owned by Houston Pharmaceuticals, Inc."}],"balance_after":2781573,"source":{"system":"sec-edgar","filing":"0001144204-17-044232","document":"v473534_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000114420417044232/v473534_4.xml","form_type":"4"}}]}